The national drug regulator on Sunday gave “emergency restricted” approval for two vaccine candidates, Covaxin, developed by Bharat Biotech, and Covis
Read MoreThe national drug regulator on Sunday gave “emergency restricted” approval for two vaccine candidates, Covaxin, developed by Bharat Biotech, and Covis
Read More